•  
  •  
  •  
  •  

2025-12-27 11:26:02

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Provigil Surveillance Ltd receives LoA from IRCTC
  • Bazel International Ltd recommends 1:1 bonus issue
  • TMB Launches Online EPF Payment Facility
  • Settlement of land disputes between NBCC India Ltd and the Government, NCT of Delhi
  • Laxmi Organic Industries Ltd clarifies on Lote facility

Keywords Selected:  UPI

Research

  • UPI transactions witnesses 118% rise at retail stores in 2023: PayNearby Report
  • UPI transactions witnesses 650% rise at rural and semi-urban stores: PayNearby
  • Lupin - Q1FY23 Result Update - Margin disappointment continues - HOLD
  • BFSI Sector Update - Connecting The Dots - UPI drags payments fee yields; BNPL endgame ahead
  • Views on announcements related to UPI payments in the RBI monetary policy today

IPO News

  • Robust QIB demand for Jupiter Hospital IPO, Issue subscribed 64 times
  • Jupiter Life Line Hospitals IPO subscribed 3.3 times on Day 2
  • Jupiter Life Line Hospitals IPO subscribed 87% on Day 1
  • Jupiter Life Line Hospitals Ltd's IPO to open on Sep 6, 2023, sets price band at ₹695 to ₹735 per Equity Share
  • Jupiter Life Line Hospitals gets SEBI Nod for IPO
  • Jupiter Life Line Hospitals raised Rs123 cr in pre -IPO round
  • Multispecialty Hospital Chain, Jupiter Life Line Hospitals files DRHP for IPO

Stock Report

  • Promoter and Promoter Group of Cupid Limited Significantly Reduce Pledge / Encumbrance of Shares
  • Axis Bank and Google Pay launch FLEX
  • Tamilnad Mercantile Bank partners with Rugr FinTech to accelerate UPI Collection through Hosted UPI Switch Tech Fini
  • Mini Diamonds India Ltd enters into MOU with Cupid Diamonds Pvt Ltd
  • BharatPe & YES BANK launch 'Pay Later with BharatPe', an instant Credit on UPI to empower merchants and ease daily consumer expenses
  • Lupin signs exclusive licensing agreement with Neopharmed for Gastroenterology Brand Plasil® in the Philippines and Brazil
  • Lupin receives Positive CHMP Opinion for Biosimilar Ranibizumab
  • Lupin receives EIR from US FDA for its Nagpur Injectable Facility
  • Lupin Secures SBTi Validation for Emission Reduction Targets
  • Lupin Manufacturing Solutions and PolyPeptide Announce Strategic Alliance to Scale Global Peptide Supply Chain
  • MobiKwik breaks into India's Top 3 Fastest-Growing UPI apps in Q2FY26
  • Cupid Breweries and Distilleries Ltd receives approval from Government of Sikkim for land lease for proposed brewing manufacturing unit
  • Lupin receives tentative approval from U.S. FDA for Siponimod Tablets
  • Lupin and Valorum Enter into an Exclusive Licensing Agreement for Biosimilar Armlupeg™ in the United States
  • Lupin Receives Approval from U.S. FDA for Biosimilar Armlupeg - Pegfilgrastim-unne
  • Lupin Foundation Earns CRISIL's Highest VO 1A Rating for Excellence in Social Responsibility
  • Info Edge India Ltd to invest in Smartweb Internet Services Ltd and Startup Investments Holding Ltd
  • Lupin Ltd receives 7 observations from USFDA for Goa manufacturing facility
  • Lupin announces closure of Inspection by U.S. FDA at its Nagpur Unit-1 Facility with No Observations
  • Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S.
  • Lupin Establishes a New Global Standard in Sustainable Pharma with an S&P Global ESG Score of 91
  • Lupin Receives EIR from U.S. FDA for its Aurangabad (CSN) Facility
  • Lupin Manufacturing Solutions Unveils Dedicated Oncology Block at Vizag, India
  • Lupin Bioresearch Center receives Zero Observations from U.S. FDA after Successful Inspection and Assessment

Industry News

  • UPI for Secondary Market
  • Cashfree Payments launches one-step UPI payment solution for mobile-first businesses

Latest Post

  • Provigil Surveillance Ltd receives LoA from IRCTC
  • Bazel International Ltd recommends 1:1 bonus issue
  • TMB Launches Online EPF Payment Facility
  • Settlement of land disputes between NBCC India Ltd and the Government, NCT of Delhi
  • Laxmi Organic Industries Ltd clarifies on Lote facility


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024